nodes	percent_of_prediction	percent_of_DWPC	metapath
Anileridine—OPRM1—epilepsy syndrome	0.527	1	CbGaD
Anileridine—Doxapram—Fosphenytoin—epilepsy syndrome	0.234	0.593	CrCrCtD
Anileridine—Doxapram—Phenytoin—epilepsy syndrome	0.16	0.407	CrCrCtD
Anileridine—OPRM1—telencephalic ventricle—epilepsy syndrome	0.00695	0.306	CbGeAlD
Anileridine—OPRM1—ganglion—epilepsy syndrome	0.00433	0.19	CbGeAlD
Anileridine—OPRM1—brainstem—epilepsy syndrome	0.00188	0.0827	CbGeAlD
Anileridine—OPRM1—forebrain—epilepsy syndrome	0.00182	0.0798	CbGeAlD
Anileridine—OPRM1—telencephalon—epilepsy syndrome	0.00167	0.0734	CbGeAlD
Anileridine—OPRM1—midbrain—epilepsy syndrome	0.0012	0.0527	CbGeAlD
Anileridine—OPRM1—spinal cord—epilepsy syndrome	0.00117	0.0514	CbGeAlD
Anileridine—OPRM1—head—epilepsy syndrome	0.00104	0.0457	CbGeAlD
Anileridine—OPRM1—nervous system—epilepsy syndrome	0.000986	0.0433	CbGeAlD
Anileridine—OPRM1—central nervous system—epilepsy syndrome	0.000949	0.0417	CbGeAlD
Anileridine—Doxapram—KCNK3—epilepsy syndrome	0.000803	0.117	CrCbGaD
Anileridine—Doxapram—KCNK9—epilepsy syndrome	0.000803	0.117	CrCbGaD
Anileridine—OPRM1—brain—epilepsy syndrome	0.000753	0.0331	CbGeAlD
Anileridine—Remifentanil—OPRD1—epilepsy syndrome	0.000378	0.0551	CrCbGaD
Anileridine—Alvimopan—OPRD1—epilepsy syndrome	0.000378	0.0551	CrCbGaD
Anileridine—Sufentanil—OPRD1—epilepsy syndrome	0.000337	0.0491	CrCbGaD
Anileridine—Remifentanil—OPRM1—epilepsy syndrome	0.000289	0.0421	CrCbGaD
Anileridine—Alvimopan—OPRM1—epilepsy syndrome	0.000289	0.0421	CrCbGaD
Anileridine—Difenoxin—OPRM1—epilepsy syndrome	0.000289	0.0421	CrCbGaD
Anileridine—Loperamide—CACNA1A—epilepsy syndrome	0.000283	0.0412	CrCbGaD
Anileridine—Diphenoxylate—OPRD1—epilepsy syndrome	0.000266	0.0388	CrCbGaD
Anileridine—Sufentanil—OPRM1—epilepsy syndrome	0.000258	0.0376	CrCbGaD
Anileridine—Diphenoxylate—OPRM1—epilepsy syndrome	0.000204	0.0297	CrCbGaD
Anileridine—Pethidine—GRIN2A—epilepsy syndrome	0.000198	0.0289	CrCbGaD
Anileridine—Loperamide—POMC—epilepsy syndrome	0.000196	0.0286	CrCbGaD
Anileridine—Pethidine—GRIN2B—epilepsy syndrome	0.000169	0.0245	CrCbGaD
Anileridine—Darifenacin—CHRM3—epilepsy syndrome	0.000152	0.0221	CrCbGaD
Anileridine—Haloperidol—GRIN2B—epilepsy syndrome	0.000144	0.021	CrCbGaD
Anileridine—Darifenacin—CHRM1—epilepsy syndrome	0.000142	0.0206	CrCbGaD
Anileridine—Darifenacin—CHRM2—epilepsy syndrome	0.000116	0.0168	CrCbGaD
Anileridine—Fentanyl—OPRD1—epilepsy syndrome	0.000115	0.0167	CrCbGaD
Anileridine—Loperamide—OPRD1—epilepsy syndrome	0.000111	0.0161	CrCbGaD
Anileridine—Pethidine—OPRM1—epilepsy syndrome	0.000108	0.0157	CrCbGaD
Anileridine—OPRM1—GPCR ligand binding—CHRM3—epilepsy syndrome	0.000108	0.00218	CbGpPWpGaD
Anileridine—OPRM1—GPCRs, Class A Rhodopsin-like—BDKRB2—epilepsy syndrome	0.000108	0.00218	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—ACKR4—epilepsy syndrome	0.000106	0.00215	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—SSTR5—epilepsy syndrome	0.000106	0.00214	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—SSTR4—epilepsy syndrome	0.000106	0.00214	CbGpPWpGaD
Anileridine—OPRM1—GPCRs, Class A Rhodopsin-like—CNR1—epilepsy syndrome	0.000106	0.00214	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CX3CR1—epilepsy syndrome	0.000103	0.00209	CbGpPWpGaD
Anileridine—OPRM1—GPCRs, Class A Rhodopsin-like—HTR7—epilepsy syndrome	0.000103	0.00208	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CCR10—epilepsy syndrome	0.000102	0.00205	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—BDKRB1—epilepsy syndrome	0.000101	0.00205	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CHRM2—epilepsy syndrome	0.000101	0.00205	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CX3CL1—epilepsy syndrome	0.000101	0.00205	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—IL1B—epilepsy syndrome	9.94e-05	0.00201	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—GABBR1—epilepsy syndrome	9.86e-05	0.00199	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR2—epilepsy syndrome	9.81e-05	0.00198	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—SST—epilepsy syndrome	9.81e-05	0.00198	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—JUN—epilepsy syndrome	9.63e-05	0.00195	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—SSTR5—epilepsy syndrome	9.63e-05	0.00195	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—SSTR4—epilepsy syndrome	9.63e-05	0.00195	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—epilepsy syndrome	9.6e-05	0.00194	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—HRH3—epilepsy syndrome	9.45e-05	0.00191	CbGpPWpGaD
Anileridine—OPRM1—Peptide ligand-binding receptors—CCR5—epilepsy syndrome	9.43e-05	0.0019	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCR10—epilepsy syndrome	9.23e-05	0.00187	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—epilepsy syndrome	9.22e-05	0.00186	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL12—epilepsy syndrome	9.22e-05	0.00186	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CNR1—epilepsy syndrome	9.05e-05	0.00183	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—GRM2—epilepsy syndrome	8.89e-05	0.0018	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—epilepsy syndrome	8.83e-05	0.00178	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CCR3—epilepsy syndrome	8.79e-05	0.00178	CbGpPWpGaD
Anileridine—Fentanyl—OPRM1—epilepsy syndrome	8.78e-05	0.0128	CrCbGaD
Anileridine—OPRM1—Peptide ligand-binding receptors—AGT—epilepsy syndrome	8.75e-05	0.00177	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—NPY—epilepsy syndrome	8.56e-05	0.00173	CbGpPWpGaD
Anileridine—Loperamide—OPRM1—epilepsy syndrome	8.46e-05	0.0123	CrCbGaD
Anileridine—OPRM1—GPCR ligand binding—OXT—epilepsy syndrome	8.26e-05	0.00167	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CRH—epilepsy syndrome	8.26e-05	0.00167	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CXCL2—epilepsy syndrome	8.26e-05	0.00167	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CCL3—epilepsy syndrome	8.26e-05	0.00167	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—GRM2—epilepsy syndrome	8.07e-05	0.00163	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—SSTR3—epilepsy syndrome	8.04e-05	0.00162	CbGpPWpGaD
Anileridine—OPRM1—G alpha (i) signalling events—CCR5—epilepsy syndrome	7.95e-05	0.00161	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—NPY2R—epilepsy syndrome	7.71e-05	0.00156	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CCR8—epilepsy syndrome	7.71e-05	0.00156	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—SSTR1—epilepsy syndrome	7.71e-05	0.00156	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CCR9—epilepsy syndrome	7.71e-05	0.00156	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—ARHGEF9—epilepsy syndrome	7.71e-05	0.00156	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—GRM4—epilepsy syndrome	7.56e-05	0.00153	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—GRM3—epilepsy syndrome	7.56e-05	0.00153	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—SST—epilepsy syndrome	7.47e-05	0.00151	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CCR2—epilepsy syndrome	7.47e-05	0.00151	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—AVP—epilepsy syndrome	7.44e-05	0.0015	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—SSTR2—epilepsy syndrome	7.42e-05	0.0015	CbGpPWpGaD
Anileridine—OPRM1—G alpha (i) signalling events—AGT—epilepsy syndrome	7.38e-05	0.00149	CbGpPWpGaD
Anileridine—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—epilepsy syndrome	7.38e-05	0.00149	CbGpPWpGaD
Anileridine—OPRM1—Peptide ligand-binding receptors—POMC—epilepsy syndrome	7.37e-05	0.00149	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—ADRA2A—epilepsy syndrome	7.31e-05	0.00148	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—SSTR3—epilepsy syndrome	7.3e-05	0.00147	CbGpPWpGaD
Anileridine—Hydroxyzine—CYP2D6—epilepsy syndrome	7.29e-05	0.0106	CrCbGaD
Anileridine—OPRM1—IL4-mediated signaling events—AKT1—epilepsy syndrome	7.23e-05	0.00146	CbGpPWpGaD
Anileridine—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—epilepsy syndrome	7.22e-05	0.00146	CbGpPWpGaD
Anileridine—Astemizole—CYP2D6—epilepsy syndrome	7.22e-05	0.0105	CrCbGaD
Anileridine—OPRM1—Peptide ligand-binding receptors—CCL2—epilepsy syndrome	7.21e-05	0.00146	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PRDM4—epilepsy syndrome	7.2e-05	0.00145	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PRICKLE1—epilepsy syndrome	7.2e-05	0.00145	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—GRM8—epilepsy syndrome	7.16e-05	0.00145	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—BDKRB2—epilepsy syndrome	7.02e-05	0.00142	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CXCL12—epilepsy syndrome	7.02e-05	0.00142	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCR8—epilepsy syndrome	7e-05	0.00141	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—SSTR1—epilepsy syndrome	7e-05	0.00141	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—NPY2R—epilepsy syndrome	7e-05	0.00141	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCR9—epilepsy syndrome	7e-05	0.00141	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—ARHGEF9—epilepsy syndrome	7e-05	0.00141	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CNR1—epilepsy syndrome	6.9e-05	0.00139	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—GRM4—epilepsy syndrome	6.86e-05	0.00139	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—GRM3—epilepsy syndrome	6.86e-05	0.00139	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—OPRD1—epilepsy syndrome	6.83e-05	0.00138	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—SSTR2—epilepsy syndrome	6.74e-05	0.00136	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—HTR7—epilepsy syndrome	6.73e-05	0.00136	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PDYN—epilepsy syndrome	6.55e-05	0.00132	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—GRM1—epilepsy syndrome	6.55e-05	0.00132	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CHRM1—epilepsy syndrome	6.55e-05	0.00132	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CCR7—epilepsy syndrome	6.55e-05	0.00132	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—GRM8—epilepsy syndrome	6.51e-05	0.00131	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—epilepsy syndrome	6.32e-05	0.00128	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—ACKR4—epilepsy syndrome	6.29e-05	0.00127	CbGpPWpGaD
Anileridine—OPRM1—G alpha (i) signalling events—POMC—epilepsy syndrome	6.21e-05	0.00126	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—OPRD1—epilepsy syndrome	6.21e-05	0.00125	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—GNAO1—epilepsy syndrome	6.21e-05	0.00125	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—epilepsy syndrome	6.19e-05	0.00125	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—GAL—epilepsy syndrome	6.16e-05	0.00124	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CHRM3—epilepsy syndrome	6.09e-05	0.00123	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—GRM5—epilepsy syndrome	6.09e-05	0.00123	CbGpPWpGaD
Anileridine—Pethidine—SLC6A4—epilepsy syndrome	5.95e-05	0.00867	CrCbGaD
Anileridine—OPRM1—Signaling by GPCR—CHRM1—epilepsy syndrome	5.95e-05	0.0012	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PDYN—epilepsy syndrome	5.95e-05	0.0012	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCR7—epilepsy syndrome	5.95e-05	0.0012	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—GRM1—epilepsy syndrome	5.95e-05	0.0012	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGT—epilepsy syndrome	5.87e-05	0.00119	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CHRM2—epilepsy syndrome	5.73e-05	0.00116	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—BDKRB1—epilepsy syndrome	5.73e-05	0.00116	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—SSTR5—epilepsy syndrome	5.69e-05	0.00115	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—SSTR4—epilepsy syndrome	5.69e-05	0.00115	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—AVP—epilepsy syndrome	5.66e-05	0.00114	CbGpPWpGaD
Anileridine—Pethidine—CYP2C19—epilepsy syndrome	5.64e-05	0.00822	CrCbGaD
Anileridine—OPRM1—Signaling by GPCR—GAL—epilepsy syndrome	5.59e-05	0.00113	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—GABBR1—epilepsy syndrome	5.57e-05	0.00113	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CHRM3—epilepsy syndrome	5.53e-05	0.00112	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—GRM5—epilepsy syndrome	5.53e-05	0.00112	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCR10—epilepsy syndrome	5.45e-05	0.0011	CbGpPWpGaD
Anileridine—OPRM1—TCR Signaling Pathway—AKT1—epilepsy syndrome	5.37e-05	0.00108	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—HRH3—epilepsy syndrome	5.34e-05	0.00108	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CX3CR1—epilepsy syndrome	5.3e-05	0.00107	CbGpPWpGaD
Anileridine—Darifenacin—CYP2D6—epilepsy syndrome	5.29e-05	0.0077	CrCbGaD
Anileridine—OPRM1—Signaling by GPCR—BDKRB1—epilepsy syndrome	5.2e-05	0.00105	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CHRM2—epilepsy syndrome	5.2e-05	0.00105	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CX3CL1—epilepsy syndrome	5.2e-05	0.00105	CbGpPWpGaD
Anileridine—Astemizole—ABCB1—epilepsy syndrome	5.16e-05	0.00751	CrCbGaD
Anileridine—OPRM1—Signaling by GPCR—GABBR1—epilepsy syndrome	5.06e-05	0.00102	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CCR3—epilepsy syndrome	4.97e-05	0.001	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	4.94e-05	0.000998	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—HRH3—epilepsy syndrome	4.85e-05	0.00098	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—NPY—epilepsy syndrome	4.84e-05	0.000978	CbGpPWpGaD
Anileridine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	4.83e-05	0.000977	CbGpPWpGaD
Anileridine—Haloperidol—CYP2C19—epilepsy syndrome	4.83e-05	0.00703	CrCbGaD
Anileridine—OPRM1—GPCR ligand binding—CCR5—epilepsy syndrome	4.81e-05	0.000973	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—GRM2—epilepsy syndrome	4.77e-05	0.000963	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—HTR2A—epilepsy syndrome	4.71e-05	0.000952	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CXCL2—epilepsy syndrome	4.67e-05	0.000943	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CRH—epilepsy syndrome	4.67e-05	0.000943	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—OXT—epilepsy syndrome	4.67e-05	0.000943	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCR3—epilepsy syndrome	4.51e-05	0.000911	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—AGT—epilepsy syndrome	4.47e-05	0.000903	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—NPY—epilepsy syndrome	4.39e-05	0.000888	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—SSTR3—epilepsy syndrome	4.31e-05	0.000871	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CXCL2—epilepsy syndrome	4.24e-05	0.000857	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCL3—epilepsy syndrome	4.24e-05	0.000857	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CRH—epilepsy syndrome	4.24e-05	0.000857	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—OXT—epilepsy syndrome	4.24e-05	0.000857	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—SST—epilepsy syndrome	4.22e-05	0.000853	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CCR2—epilepsy syndrome	4.22e-05	0.000853	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—ST3GAL3—epilepsy syndrome	4.22e-05	0.000853	CbGpPWpGaD
Anileridine—Pethidine—CYP2D6—epilepsy syndrome	4.18e-05	0.00609	CrCbGaD
Anileridine—OPRM1—Signaling Pathways—ARHGEF9—epilepsy syndrome	4.13e-05	0.000835	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCR8—epilepsy syndrome	4.13e-05	0.000835	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—SSTR1—epilepsy syndrome	4.13e-05	0.000835	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCR9—epilepsy syndrome	4.13e-05	0.000835	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NPY2R—epilepsy syndrome	4.13e-05	0.000835	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—ADRA2A—epilepsy syndrome	4.13e-05	0.000835	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—GRM4—epilepsy syndrome	4.05e-05	0.000819	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—GRM3—epilepsy syndrome	4.05e-05	0.000819	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—DUSP4—epilepsy syndrome	3.98e-05	0.000804	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—SSTR2—epilepsy syndrome	3.98e-05	0.000804	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CXCL12—epilepsy syndrome	3.97e-05	0.000802	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—BDKRB2—epilepsy syndrome	3.97e-05	0.000802	CbGpPWpGaD
Anileridine—Haloperidol—HTR2A—epilepsy syndrome	3.91e-05	0.0057	CrCbGaD
Anileridine—OPRM1—GPCR downstream signaling—CNR1—epilepsy syndrome	3.9e-05	0.000787	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—PLCB1—epilepsy syndrome	3.88e-05	0.000784	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—GRM8—epilepsy syndrome	3.84e-05	0.000777	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PGF—epilepsy syndrome	3.84e-05	0.000777	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCR2—epilepsy syndrome	3.83e-05	0.000775	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—SST—epilepsy syndrome	3.83e-05	0.000775	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—HTR7—epilepsy syndrome	3.8e-05	0.000768	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—POMC—epilepsy syndrome	3.76e-05	0.00076	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—ADRA2A—epilepsy syndrome	3.75e-05	0.000758	CbGpPWpGaD
Anileridine—OPRM1—GPCR ligand binding—CCL2—epilepsy syndrome	3.68e-05	0.000744	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—GNAO1—epilepsy syndrome	3.67e-05	0.000741	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—OPRD1—epilepsy syndrome	3.67e-05	0.000741	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—AKT3—epilepsy syndrome	3.62e-05	0.000732	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—BDKRB2—epilepsy syndrome	3.6e-05	0.000728	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CXCL12—epilepsy syndrome	3.6e-05	0.000728	CbGpPWpGaD
Anileridine—Haloperidol—CYP2D6—epilepsy syndrome	3.58e-05	0.00521	CrCbGaD
Anileridine—OPRM1—Signaling by GPCR—CNR1—epilepsy syndrome	3.54e-05	0.000715	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PLCB1—epilepsy syndrome	3.53e-05	0.000712	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CHRM1—epilepsy syndrome	3.51e-05	0.00071	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—GRM1—epilepsy syndrome	3.51e-05	0.00071	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PDYN—epilepsy syndrome	3.51e-05	0.00071	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCR7—epilepsy syndrome	3.51e-05	0.00071	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—HTR7—epilepsy syndrome	3.45e-05	0.000698	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—HBEGF—epilepsy syndrome	3.35e-05	0.000677	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CDC42—epilepsy syndrome	3.31e-05	0.000668	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—GFAP—epilepsy syndrome	3.3e-05	0.000668	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—GAL—epilepsy syndrome	3.3e-05	0.000668	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—AKT3—epilepsy syndrome	3.29e-05	0.000665	CbGpPWpGaD
Anileridine—Loperamide—CYP2D6—epilepsy syndrome	3.27e-05	0.00477	CrCbGaD
Anileridine—OPRM1—Signaling Pathways—CHRM3—epilepsy syndrome	3.27e-05	0.00066	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—GRM5—epilepsy syndrome	3.27e-05	0.00066	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CASP2—epilepsy syndrome	3.27e-05	0.00066	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—AVP—epilepsy syndrome	3.2e-05	0.000647	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CX3CR1—epilepsy syndrome	3.13e-05	0.000633	CbGpPWpGaD
Anileridine—Pethidine—ALB—epilepsy syndrome	3.13e-05	0.00456	CrCbGaD
Anileridine—OPRM1—Signaling Pathways—CX3CL1—epilepsy syndrome	3.07e-05	0.000621	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CHRM2—epilepsy syndrome	3.07e-05	0.000621	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—BDKRB1—epilepsy syndrome	3.07e-05	0.000621	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CDC42—epilepsy syndrome	3e-05	0.000606	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—GABBR1—epilepsy syndrome	2.99e-05	0.000604	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—AVP—epilepsy syndrome	2.91e-05	0.000587	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—HRH3—epilepsy syndrome	2.87e-05	0.000579	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—CCR5—epilepsy syndrome	2.72e-05	0.00055	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCR3—epilepsy syndrome	2.66e-05	0.000538	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.66e-05	0.000538	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NPY—epilepsy syndrome	2.6e-05	0.000525	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—ATP2A2—epilepsy syndrome	2.6e-05	0.000525	CbGpPWpGaD
Anileridine—Haloperidol—ABCB1—epilepsy syndrome	2.56e-05	0.00372	CrCbGaD
Anileridine—OPRM1—GPCR downstream signaling—AGT—epilepsy syndrome	2.53e-05	0.00051	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—HSPB1—epilepsy syndrome	2.5e-05	0.000506	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CXCL2—epilepsy syndrome	2.5e-05	0.000506	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCL3—epilepsy syndrome	2.5e-05	0.000506	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CRH—epilepsy syndrome	2.5e-05	0.000506	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—OXT—epilepsy syndrome	2.5e-05	0.000506	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCR5—epilepsy syndrome	2.47e-05	0.000499	CbGpPWpGaD
Anileridine—Fentanyl—ABCB1—epilepsy syndrome	2.43e-05	0.00353	CrCbGaD
Anileridine—OPRM1—Signaling by GPCR—HTR2A—epilepsy syndrome	2.42e-05	0.000489	CbGpPWpGaD
Anileridine—Loperamide—ABCB1—epilepsy syndrome	2.34e-05	0.0034	CrCbGaD
Anileridine—OPRM1—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.33e-05	0.000472	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—TSC1—epilepsy syndrome	2.33e-05	0.00047	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PTK2B—epilepsy syndrome	2.33e-05	0.00047	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—AGT—epilepsy syndrome	2.29e-05	0.000464	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCR2—epilepsy syndrome	2.26e-05	0.000458	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—SST—epilepsy syndrome	2.26e-05	0.000458	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NTRK2—epilepsy syndrome	2.26e-05	0.000458	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—DUSP6—epilepsy syndrome	2.25e-05	0.000454	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	2.22e-05	0.000448	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PLAT—epilepsy syndrome	2.21e-05	0.000446	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CXCL12—epilepsy syndrome	2.13e-05	0.00043	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	2.13e-05	0.00043	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—POMC—epilepsy syndrome	2.13e-05	0.00043	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	2.12e-05	0.000428	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	2.11e-05	0.000427	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—JUNB—epilepsy syndrome	2.09e-05	0.000422	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CNR1—epilepsy syndrome	2.09e-05	0.000422	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PLCB1—epilepsy syndrome	2.08e-05	0.000421	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—HTR7—epilepsy syndrome	2.04e-05	0.000412	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—HBEGF—epilepsy syndrome	1.98e-05	0.0004	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—AKT3—epilepsy syndrome	1.94e-05	0.000393	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—POMC—epilepsy syndrome	1.93e-05	0.00039	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—ADAM10—epilepsy syndrome	1.9e-05	0.000384	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—CCL2—epilepsy syndrome	1.89e-05	0.000382	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—S100B—epilepsy syndrome	1.79e-05	0.000363	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—SOCS3—epilepsy syndrome	1.78e-05	0.000359	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CDC42—epilepsy syndrome	1.77e-05	0.000358	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—AVP—epilepsy syndrome	1.72e-05	0.000347	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—HES1—epilepsy syndrome	1.62e-05	0.000328	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—FYN—epilepsy syndrome	1.58e-05	0.000319	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—H2AFX—epilepsy syndrome	1.57e-05	0.000318	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—MEF2C—epilepsy syndrome	1.57e-05	0.000317	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.52e-05	0.000307	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—NGF—epilepsy syndrome	1.5e-05	0.000303	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCR5—epilepsy syndrome	1.46e-05	0.000295	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—HTR2A—epilepsy syndrome	1.43e-05	0.000289	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—TSC2—epilepsy syndrome	1.36e-05	0.000274	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—AGT—epilepsy syndrome	1.36e-05	0.000274	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—APOE—epilepsy syndrome	1.33e-05	0.000268	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—KDR—epilepsy syndrome	1.3e-05	0.000263	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—PRKCB—epilepsy syndrome	1.25e-05	0.000253	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—IL6ST—epilepsy syndrome	1.25e-05	0.000252	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—POMC—epilepsy syndrome	1.14e-05	0.00023	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CCL2—epilepsy syndrome	1.12e-05	0.000226	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—FGF2—epilepsy syndrome	1.01e-05	0.000204	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—RELA—epilepsy syndrome	9.36e-06	0.000189	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—MTOR—epilepsy syndrome	9.18e-06	0.000186	CbGpPWpGaD
Anileridine—OPRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	8.52e-06	0.000172	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—CASP3—epilepsy syndrome	8.45e-06	0.000171	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—JUN—epilepsy syndrome	8.2e-06	0.000166	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—MMP9—epilepsy syndrome	7.98e-06	0.000161	CbGpPWpGaD
Anileridine—OPRM1—Signaling by GPCR—AKT1—epilepsy syndrome	7.74e-06	0.000156	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—SRC—epilepsy syndrome	7.36e-06	0.000149	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—VEGFA—epilepsy syndrome	7.17e-06	0.000145	CbGpPWpGaD
Anileridine—OPRM1—Signaling Pathways—AKT1—epilepsy syndrome	4.57e-06	9.24e-05	CbGpPWpGaD
